72 related articles for article (PubMed ID: 7875501)
1. Does HLA status influence prognosis in primary sclerosing cholangitis?
Chapman R
Gastroenterology; 1995 Mar; 108(3):937-40. PubMed ID: 7875501
[No Abstract] [Full Text] [Related]
2. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.
Olerup O; Olsson R; Hultcrantz R; Broome U
Gastroenterology; 1995 Mar; 108(3):870-8. PubMed ID: 7875491
[TBL] [Abstract][Full Text] [Related]
3. Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis.
Farrant JM; Doherty DG; Donaldson PT; Vaughan RW; Hayllar KM; Welsh KI; Eddleston AL; Williams R
Hepatology; 1992 Aug; 16(2):390-5. PubMed ID: 1639348
[TBL] [Abstract][Full Text] [Related]
4. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis.
Broomé U; Glaumann H; Hultcrantz R; Forsum U
Scand J Gastroenterol; 1990 Jan; 25(1):54-8. PubMed ID: 2406888
[TBL] [Abstract][Full Text] [Related]
5. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.
Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R
Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806
[TBL] [Abstract][Full Text] [Related]
6. HLA antigens in ulcerative colitis and primary sclerosing cholangitis.
Leidenius MH; Koskimies SA; Kellokumpu IH; Höckerstedt KA
APMIS; 1995; 103(7-8):519-24. PubMed ID: 7576567
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on haplotypes of five HLA loci in southern Chinese Han population by sequence-based typing].
Gao SQ; Zou HY; Cheng LH; Jing SZ; Deng ZH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):228-32. PubMed ID: 19350523
[TBL] [Abstract][Full Text] [Related]
8. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings.
Habior A; Rawa T; Orłowska J; Sankowska M; Lewartowska A; Tilszer A; Pawlak J; Krawczyk M; Butruk E
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):787-91. PubMed ID: 12169991
[TBL] [Abstract][Full Text] [Related]
9. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.
Zetterquist H; Broomé U; Einarsson K; Olerup O
Gut; 1992 Jul; 33(7):942-6. PubMed ID: 1644334
[TBL] [Abstract][Full Text] [Related]
10. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
11. Association between type 1 diabetes age of onset and HLA among sibling pairs.
Valdes AM; Thomson G; Erlich HA; Noble JA
Diabetes; 1999 Aug; 48(8):1658-61. PubMed ID: 10426387
[TBL] [Abstract][Full Text] [Related]
12. Association of primary sclerosing cholangitis with HLA-DRw52a.
Prochazka EJ; Terasaki PI; Park MS; Goldstein LI; Busuttil RW
N Engl J Med; 1990 Jun; 322(26):1842-4. PubMed ID: 2348837
[TBL] [Abstract][Full Text] [Related]
13. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus.
Gao XH; Barnardo MC; Winsey S; Ahmad T; Cook J; Agudelo JD; Zhai N; Powell JJ; Fuggle SV; Wojnarowska F
J Invest Dermatol; 2005 Nov; 125(5):895-9. PubMed ID: 16297186
[TBL] [Abstract][Full Text] [Related]
14. HLA and Hashimoto's thyroiditis in Sichuan, China.
Pei J; Yang Z; Zhu DY; Hou ZC; Sun SX; Mi XY; Wang LH
Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(2):116-20. PubMed ID: 3423008
[No Abstract] [Full Text] [Related]
15. Resistance to autoimmune thyroid disease is associated with HLA-DQ.
Tamai H; Kimura A; Dong RP; Matsubayashi S; Kuma K; Nagataki S; Sasazuki T
J Clin Endocrinol Metab; 1994 Jan; 78(1):94-7. PubMed ID: 8288722
[TBL] [Abstract][Full Text] [Related]
16. HLA and multiple sclerosis in Chinese.
Pei J; Xu WZ; Sun SX; Mi XY; Hou ZC; Wang LH
Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(2):111-5. PubMed ID: 3423007
[No Abstract] [Full Text] [Related]
17. HLA-DRB1*03 and DQB1*0302 associations in a subset of patients severely affected with systemic lupus erythematosus from western India.
Shankarkumar U; Ghosh K; Badakere SS; Mohanty D
Ann Rheum Dis; 2003 Jan; 62(1):92-3. PubMed ID: 12480686
[No Abstract] [Full Text] [Related]
18. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR-DQ haplotype frequencies in a Norwegian population.
Spurkland A; Rønningen KS; Leivestad T; Vartdal F; Thorsby E
Transplant Proc; 1992 Feb; 24(1):298-9. PubMed ID: 1539285
[No Abstract] [Full Text] [Related]
20. Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: back to the future with human leukocyte antigen DRβ.
Donaldson PT
Hepatology; 2011 Jun; 53(6):1798-800. PubMed ID: 21538433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
